GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sirio Pharma Co Ltd (SZSE:300791) » Definitions » EV-to-FCF

Sirio Pharma Co (SZSE:300791) EV-to-FCF : -273.20 (As of Apr. 10, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Sirio Pharma Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sirio Pharma Co's Enterprise Value is ¥6,619 Mil. Sirio Pharma Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-24 Mil. Therefore, Sirio Pharma Co's EV-to-FCF for today is -273.20.

The historical rank and industry rank for Sirio Pharma Co's EV-to-FCF or its related term are showing as below:

SZSE:300791' s EV-to-FCF Range Over the Past 10 Years
Min: -342.44   Med: -34.06   Max: 513.13
Current: -309.24

During the past 12 years, the highest EV-to-FCF of Sirio Pharma Co was 513.13. The lowest was -342.44. And the median was -34.06.

SZSE:300791's EV-to-FCF is ranked worse than
100% of 1203 companies
in the Consumer Packaged Goods industry
Industry Median: 16.88 vs SZSE:300791: -309.24

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-10), Sirio Pharma Co's stock price is ¥25.14. Sirio Pharma Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.541. Therefore, Sirio Pharma Co's PE Ratio (TTM) for today is 16.31.


Sirio Pharma Co EV-to-FCF Historical Data

The historical data trend for Sirio Pharma Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirio Pharma Co EV-to-FCF Chart

Sirio Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.75 107.69 -38.96 39.65 -108.24

Sirio Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 417.67 -108.24 -48.97 -85.78 -336.48

Competitive Comparison of Sirio Pharma Co's EV-to-FCF

For the Packaged Foods subindustry, Sirio Pharma Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirio Pharma Co's EV-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Sirio Pharma Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sirio Pharma Co's EV-to-FCF falls into.


;
;

Sirio Pharma Co EV-to-FCF Calculation

Sirio Pharma Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6619.389/-24.229
=-273.20

Sirio Pharma Co's current Enterprise Value is ¥6,619 Mil.
Sirio Pharma Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirio Pharma Co  (SZSE:300791) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Sirio Pharma Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=25.14/1.541
=16.31

Sirio Pharma Co's share price for today is ¥25.14.
Sirio Pharma Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.541.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sirio Pharma Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sirio Pharma Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirio Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
No. 83, Taishan Road, Guangdong Province, Shantou, CHN, 515057
Sirio Pharma Co Ltd is engaged in the research and development, production, sales and technical services of nutrition and health food, food production, sales, import and export of goods.
Executives
Chen Qiong Directors, executives
Yao Zhuang Min Directors, executives
Zheng Li Qun Directors, executives
Yang Rui Directors, executives

Sirio Pharma Co Headlines

No Headlines